Trial Profile
Dutasteride (0.5mg) Once Daily for One Year and Tamsulosin (0.4mg) Once Daily for 3 Months, Followed by Counseling on Flex Dose Tamsulosin as Needed on Improvement of Symptoms and Outcome in Men With Moderate to Severe Symptomatic BPH
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Tamsulosin
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 02 Aug 2011 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.